443
Participants
Start Date
March 1, 2022
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2024
Immunobiogram
This is not an interventional study. However the assay being tested on the blood samples of all enrolled participants is the Immunobiogram (IMBG). IMBG is an in vitro diagnostic immunoassay which can obtain dose-response curves that describe the inhibitory effect of each immunosuppressant on immune response cells (immunologically stimulated PBMCs) in kidney transplant patients.
Hospital Do Rim, Brasil
University Hospital Grenoble, Grenoble
Charité Universitätsmedizin Berlin, Berlin
Universitätsklinikum Heidelberg, Heidelberg
Fundació Puigvert, Barcelona
Hospital Clínic de Barcelona, Barcelona
Hospital del Mar, Barcelona
Hospital Universitario Puerta del Mar, Cadiz
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Puerta de Hierro, Madrid
Hospital Universitario Marqués de Valdecilla, Santander
Hospital Universitario Dr. Peset, Valencia
Uppsala University Hospital, Uppsala
Biohope Scientific Solutions for Human Health, S.L.
INDUSTRY